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Prior  studies  have  shown  that  mouse peritoneal  macrophages  contain  unusually 
high levels of arachidonic acid (20:4)1 in their phospholipids. Under resting conditions 
of in vitro cultivation, 20:4 is retained in cell phospholipids and insignificant amounts 
are  metabolized  via  lipoxygenase  and  cyclo-oxygenase pathways  (1,  2).  However, 
when stimulated by the appropriate membrane-perturbing agents of both soluble and 
particulate nature  (1-3), up to 50% of the 20:4 is released  in the form of oxygenated 
metabolites.  Release occurs under conditions in which tritiated  20:4 has been previ- 
ously incorporated into phospholipids  (1)  and leads to the formation of radiolabeled 
prostaglandins,  hydroxyeicosatetraenoic  acids  (HETEs),  and  leukotriene  C,  a  slow- 
reacting substance  (1-2, 4, 5). 
In this paper we report the unique response of resting macrophages to exogenously 
supplied 20:4 and its rapid metabolism in the absence of phagocytic or pharmacologic 
stimuli.  We show that within 5 rain approximately one-third of the radiolabeled  20: 
4 supplied in serum-free medium is incorporated into cell phospholipids and approx- 
imately  two-thirds  is  converted  to  a  spectrum  of oxygenated  products--primarily 
prostacyclin and HETEs. Qualitatively different results are obtained when Corynebac- 
terium parvum-elicited  macrophages are employed. 
Materials and Methods 
Macrophage  Cultures.  Primary  cultures  of peritoneal  macrophages  were  established  from 
resident cells of female and male Swiss Webster (Taconic Farms, Germantown, N. Y.) or CD- 
1 (The Trudeau Institute, Saranae Lake, N. Y.) mice, as previously described (1). Approximately 
6 ×  10  e peritoneal cells suspended in  1 ml of minimum essential  a  medium (a-MEM, Grand 
Island Biological Co., Grand Island, N. Y.) containing 10% fetal calf serum (FCS)  were added 
to 35-ram Diam plastic culture dishes.  After 2 h  at  37°C in 5% CO2/95% air, cultures were 
washed three times in calcium and magnesium-free phosphate buffered saline (PD) to remove 
nonadherent cells and incubated overnight (16 h) in fresh a-MEM plus  10% FCS. 
C. parvum-elicited Macrophages.  C. parvum-elicited peritoneal macrophages were obtained from 
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l Abbreviations used in this paper." a-MEM, minimal essential alpha medium; ETYA, 5,8,11,14-eicosatetray- 
noic acid;  FCS, fetal calf serum; 5-HETE,  5-hydroxy-6,8,11,14-eicosatetraenoie acid;  12-HETE, 12- 
hydroxy-5,8,10,14-eicosatetraenoic acid;  15-HETE, 15-hydroxy-5,8,11,13-eicosatetraenoic acid;  HPLC, 
reverse-phase high performance liquid chromatography; 6-keto-PGFl,, 6-keto prostaglandin FI~; NDGA, 
nordihydroguaiaretie acid; PD, calcium and magnesium-free phosphate buffered saline; PGE2, prostaglan- 
din E2; PGFz,, prostaglandin F2~; 20:4, arachidonic acid; TXB2, thromboxane B~. 
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mice injected intraperitoneally 11-14 d before harvest with 1.4 mg of formalin-killed C. parvum 
(Coparvax; a generous gift of Dr. R. Tuttle, Burroughs Wellcome Co., Greenville, N. C.). 
Synthesis of 20:4 Oxygenated Products.  At the end of the overnight incubation period, macro- 
phage cultures were washed three times with cold PD and overlaid with 1 ml of fresh a-MEM 
(no serum) containing 0.5/~Ci of [5,6,8,9,11,12,14,15-3H]20:4  ([3H]20:4)  (62.2 Ci/mmol sp act; 
New England Nuclear, Boston, Mass.) or [SH]20:4 and the indicated concentration of unlabeled 
20:4  (Nu-Chek-Prep,  Inc.,  Elysian,  Minn.).  Media were  removed  after  incubation  for  the 
appropriate periods under 5% CO2/95% air at 37°C. Cell monolayers were washed twice with 
PD, overlaid with 1 ml 0.05% Triton X-100 (Rohm and Haas Co., Philadelphia, Pa.), and the 
dishes were scraped. 50/~1 aliquots of media and Triton X-100 cell lysates were removed for 
radioactivity determinations. The protein content of cell lysates was determined by the method 
of Lowry et al. (6) with bovine serum albumin as a standard. The protein content of cultures 
in 35-mm dishes was 94 +  18 #g (n =  50). 
20:4 metaholites were extracted from culture media following a modification of the procedure 
described by Unger et al. (7). In brief, 1 vol of absolute ethanol was added. After acidification 
with formic acid (85% wt/wt;  10 p,l/ml of medium, final pH ~3), media were extracted twice 
with  1 vol each of chloroform. The chloroform phases were combined and  taken to dryness 
under a stream of nitrogen. The 20:4 metabolites were resuspended in 1 ml of chloroform and 
again taken to dryness. This procedure was repeated twice before the 20:4 metabolites were 
dissolved in 0.5 ml of the appropriate starting buffer for reverse-phase high performance liquid 
chromatography (HPLC). 
20:4 metabolites were separated and identified by HPLC on columns (4.6 mm ×  25 cm) of 
uhrasphere C-18 (Ahex Scientific, Inc., Beckman Instruments, Inc., Berkeley, Calif.) at a flow 
rate of 1 ml/min. Fractions of 1 ml were collected. The contents of fractions were dried under 
a stream of air and radioactivity was measured by liquid scintillation counting in Hydrofluor 
(National Diagnostics, Inc., Advanced Applications Institute, Inc., Sommerville, N. J.). Pros- 
taglandins, HETEs,  and  20:4 were resolved using the conditions described by Borgeat  and 
Samuelsson (8) for the resolution of HETEs. Columns were eluted isocratically with 80 ml of 
solvent 1 (methanol/water/acetic acid, 75:25:0.01, vol/vol/vol) followed by 40 ml of solvent 2 
(methanol/acetic acid, 100:0.01,  vol/vol). For the identification of prostaglandins, fractions 4- 
10 were pooled, dried under a steam of nitrogen, and the residue dissolved in solvent 3 (water/ 
acetonitrile/benzene/acetic acid, 76.7:23.0:0.2:0.1, vol/vol/vol/vol). Separation of prostaglan- 
dins was achieved by HPLC in the same solvent. Leukotriene C was separated from other 20: 
4 metabolites by HPLC of medium extracts using solvent 4  (methanol/water/acetic acid, 65: 
35:0.1, pH 5.4,  vol/vol/vol). Prior to chromatography, the chloroform extracts were taken to 
dryness under a stream of nitrogen (above), however, the vessel was washed with ethanol/water 
(80:20,  vol/vol). The  20:4  metabolites were  finally dissolved in  0.5  ml  of solvent  4  before 
application to the column. 
3  3  H-labeled Standards.  H-labeled standards were subjected to the same HPLC procedures for 
purposes of identification. 3H-labeled prostaglandins including prostaglandin E2 (PGE2), pros- 
taglandin F2, (PGF2~), 6-keto prostaglandin FI~ (6-ketoPGFl~), and thromboxane B2 (TXB2) 
were purchased from New England Nuclear. 3H-labeled 5-hydroxy-6,8,11,14-eicosatetraenoic 
acid  (5-HETE),  12-hydroxy-5,8,10,14-eicosatetraenoic  acid  (12-HETE),  and  15-hydx~o_xy- 
5,8,11,13-eieosatetraenoic  acid  (15-HETE)  were  generated  by  published  procedures  using 
[3H]20:4  as the substrate. 5-HETE was obtained from human neutrophils (8),  12-HETE from 
human  platelets (10),  and  15-HETE after incubation of [ZH]20:4  with soybean lipoxygenase 
(11).  Each HETE  was extracted from culture medium or the reaction mixture as described 
above, and purified by HPLC in solvent 1. 
Inhibitors of Cyclo-oxygenase and Lipoxygenase.  Nordihydroguaiaretic acid (NDGA) and indo- 
methacin were obtained from Sigma Chemical Co., St. Louis, Mo. 5,8,11,14  eicosatetraynoic 
acid (ETYA) was kindly provided by Dr. W. E. Scott, Hoffman-LaRoche, Inc., Nutley, N. J. 
Stock solutions of NDGA (3 mg/ml) and indomethacin (1 mg/ml) were prepared in absolute 
ethanol  and  diluted  into  a-MEM.  ETYA  stocks  (0.87  mg/ml)  in  hexane-ethanol  mixture 
(10:1)  were diluted in hexane before use. 
Kinetics of [3H]20:4  Uptake by Macrophage Cultures.  Explanted macrophages were cultured 
overnight in a-MEM plus 10% FCS as described above. Cultures were placed on ice, washed SCOTT,  PAWLOWSKI, ANDREACH, AND COHN  537 
twice with PD, and overlaid with 1 ml ofa-MEM containing 0.5 #Ci of [3H]20:4. The PD and 
a-MEM were precooled to 4°C before use. Cultures were transferred to 37°C and incubated 
under an atmosphere of 5% COg/95% air.  At the indicated times,  duplicate 35-ram cultures 
were placed on ice, and the medium was removed. Cells were washed twice and scraped into 
PD preeooled to 4~C. Duplicate a|iquots of media and ceils suspended in PD were removed for 
radioactivity determinations. 
Cell lipids  were immediately extracted at 4°C, following  the procedure of Bligh and Dyer 
(12). Individual phospholipids were separated by two-dimensional thin-layer chromatography 
(1) on plates of silica gel (2-D Redi Coats, Supelco, Inc., Bellefonte,  Pa.). The organic phase of 
cell extracts was concentrated under nitrogen, spotted on plates, and overlaid with 0.1 #tool of 
carrier lipid (nonradioactive) extracted from the macrophage-like cell line J774. Chromatograms 
were developed in the first dimension with chloroform/methanol/ammonium hydroxide (65: 
35:5, vol/vol/vol) and  in  the second  dimension with chloroform/acetone/methanol/acetone 
acid/water (30:40:10:10:5,  vol/vol/vol/vol/vot) (13). Lipid containing regions were visualized 
by  a  brief exposure  of plates  to  iodine  vapors and  were  scraped  into  scintillation  vials. 
Radioactivity was determined in Hydrofluor after the addition of water (1 ml). 
Results 
Incorporation ¢20:4 by Macrophages in Serum-free Medium.  Fig.  1A shows the kinetics 
of [SH]20:4  incorporation  by  macrophages  incubated  in  serum-free a-MEM.  The 
uptake of fatty acid increased  linearly for 5-10 rain. After this time, the amount of 
radiolabel in the culture medium remained constant or decreased at a much reduced 
rate. Maximal levels of 20:4  incorporation  reached  34.8  -)-  10.0%  (mean +  SD, n = 
10)  of the fatty acid supplied to the medium and this value was independent  of the 
exogenous fatty acid concentration  over the range of 10  nM  to  1 #M.  Exposure of 
macrophages to 20:4 concentrations >I #M for periods of t-2 h  ted to cell death, as 
determined  by trypan blue exclusion.  Although  we were unable to determine satu- 
rating levels of 20:4, it is evident that macrophages have a  considerable capacity for 
20:4 uptake. 
Figure  1 B  shows  the  distribution  of radiolabel  in  macrophage phospholipids  at 
various times following exposure of serum-free cultures to [~H]20:4. At all time points, 
90-95%  of the incorporated  fatty acid was recovered in phospholipid.  In the initial 
portion of the labeling period, the highest percentage of radiolabel was incorporated 
into phosphatidylinositol and the major macrophage phospholipid, phosphatidylcho- 
line.  Subsequently~  the  relative  amounts  of radiolabel  in  phosphatidylinositol  de- 
creased with a concomitant increase in the radiolabel content ofphosphatidylcholine. 
The  amount  of SH  in  phosphatidylethanolamine,  in  contrast,  remained  constant. 
Overall, this labeling pattern is similar to that seen during the longer time course (24 
h)  of 20:4 uptake by macrophages maintained in serum containing medium, which 
was linear over a  8  h  period  (1).  Two exceptions,  however, are notable.  In  serum 
cultures,  a  higher  percentage  (30%)  of radiolabel  was  recovered  in  neutral  lipid. 
Furthermore,  the SH content  of phosphatidylethanolamine  increased  to 40% of the 
total radiolabel in phospholipid with decreases in SH levels of both phosphatidylcho- 
line  and  phosphatidylinositol  as  a  function  of  labeling  time.  These  distinctions, 
however, may result from differences in the exposure time of cultures to [SH]20:4 in 
addition to effects of serum~ 
Conversion of Exogenously Supplied 20.'4 to Oxygenated ~tabolites.  The abrupt cessation 
of 20:4 incorporation into phospholipid illustrated in Fig.  I A was explained when the 
culture medium was extracted and subjected to HPLC under conditions that allowed 
mutual separation of prostaglandins, HETEs, and unreacted 20:4  (Fig.  2).  Recovery 538  MACROPHAGE  ARACHIDONIC  ACID  METABOLISM 
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Fro.  1.  Uptake of [all]20:4  by macrophage cultures in serum-free 0t-MEM and distribution of 
[aH]20:4  among macrophage lipids. Cultures were incubated overnight, washed with cold PD, and 
overlaid with cold a-MEM containing 0.5 #Ci of [3H]20:4.  At time = 0, the cultures were transferred 
to 37°12.  (A)  Time-course of [aH]20:4  uptake by macrophages and aH content of medium. The 
medium was removed from duplicate cultures at the indicated times. Cell monolayers were rinsed 
in  the cold and scraped into 0.05% Triton  X-100.  Radioactivity was  determined in aliquots of 
medium (O) and Triton cell lysates (0). Values are means +  range. (B) Percentage of incorporated 
radiolabel in macrophage phospholipids and neutral lipid as a  function of exposure time to [aH]- 
20:4. The protocol was identical to that in (A) except that ceils were scraped into PD and the lipids 
extracted. The lipid extracts were subjected to two-dimensional thin layer chromatography. Areas 
of the chromatograms containing lipid were scraped and the radioactivity of each was determined. 
Data are expressed as the percentage of recovered radiolabel, rq, phosphatidylcholine; [], phospha- 
tidylethanolamine; [], phosphatidylinositol; E, phosphatidylinositol; [], neutral lipid. Less than 1% 
of the radiolabel in lipid extracts of cells was present as free fatty acid. The total percentage of 
radiolabel in other macrophage phospholipids, including phosphatidylserine, sphingomyelin, and 
cardiolipin was low (<2%) and did not vary during the labeling period. The SEM was <5%. 
of the radiolabel on extraction was quantitative (>95%). The major percentage of the 
radiolabel (80%)  was resolved by HPLC into a  number of compounds considerably 
more  polar  than  20:4  (Fig.  2).  This  suggested  extensive  metabolism  of 20:4  by 
macrophages. Few or none of these products were evident in controls that consisted 
of incubating  [3H]20:4-containing  medium  in  the  absence  of cells  (Fig.  2).  The 
predominant  20:4  metabolites  in  peak  1  (Fig.  2,  fractions 4-10)  contained  cyclo- 
oxygenase products. Considerable radioactivity was also recovered in the region of 
the  chromatogram  corresponding  to  the  elution  times  (8)  of di-  and  tri-HETEs 
(fractions  11-25)  in addition  to mono-HETEs (fractions 28-40).  Several criteria in 
addition  to  elution  characteristics on  HPLC  are  consistent  with  this  radiolabeled 
material being HETEs and include: (a) elution times of 5-HETE, 12-HETE, and  15- 
HETE standards (25-40 rain), (b) the similar Rf values of these macrophage products 
and  HETEs  standards  on  thin  layer  chromatography  (1),  and  (c)  the  reduced SCOTT,  PAWLOWSKI,  A~'qDREACH,  AND  COHN  539 
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Fla.  2.  HPLC chromatograms of all-labeled products in culture medium after a 20 rain incubation 
with 0.5 #Ci  of [nil]20:4.  ~  ),  Products formed by resident peritoneal  maerophages. Cultures 
were incubated overnight in a-MEM plus 10% FCS, rinsed, and overlaid with a-MEM containing 
[all]20:4.  Incubation with [all]20:4 was for 20 min at 37°C.  (- -  -), No cell control. Medium plus 
[aH]20:4 was incubated  for 20 rain  in culture dishes without macrophages. Media samples were 
extracted as described under Materials and Methods. Prostaglandins and HETEs were separated 
on an ultrasphere C-18 column in solvent  1. Arrow indicates the point at which the column was 
treated with solvent 2 to elute unreacted 20:4. Prostaglandin standards (6-ketoPGF~,~,  PGF~, PGE2, 
and thromboxane ]32) were eluted in fractions 4-11; 5-HETE,  12-HETE, and  15-HETE standards 
in fractions 30-40; and 20:4 in fractions 94-96. 
quantities of these 20:4 products formed by macrophages pre-treated with NDGA, a 
lipoxygenase inhibitor (below). HPLC of medium extracts in solvent 4, which resolves 
leukotriene C  from other 20:4 metabolites, indicated that <3% of the radiolabel was 
converted to slow reacting substance (C.  Rouzer, personal communication). 
The cyclo-oxygenase products formed from exogenously supplied 20:4 were iden- 
tified by subjecting the pooled material in peak 1 (Fig. 2) to HPLC in solvent 3. Peak 
1 resolved into some very polar material  that  eluted  at  the solvent  front  (Fig.  3). 
According to Bokoch and Reed (14) phospholipid may be found in this peak. Peak 1 
further resolved into  a  major peak  of radiolabel  that  coeluted with  6-keto  PGFI~ 
(fractions 19-23), a peak of PGE2 (fractions 82-89), and a small peak of unidentified 
material (fractions 31-36). The ratio of 6-keto PGFI~ to PGE2 ranged from 2.7 to 4.0 
(n -- 4). This was considerably different from a  ratio of 0.66 for the same products 
synthesized  from  endogenous  20:4  released  by  cultures  exposed  to  a  phagocytic 
stimulus  (W.  A.  Scott,  unpublished  results).  Approximately  22  and  45%  of the 
radiolabel was recovered as cyclo-oxygenase and lipoxygenase products, respectively. 
Of the  remaining  radiolabel,  20%  was  recovered  as  unreacted  20:4  and  14%  as 
unidentified 20:4 metabolites. 
Cyclo-oxygenase and Lipoxygenase Inhibitors.  The influence of lipoxygenase or cyclo- 
oxygenase inhibitors on the metabolism of exogenously supplied  [aH]20:4 was  next 
examined. The percentage of metabolites formed was estimated from HPLC elution 
profiles. As shown in Table I, pre-exposure of cultures to indomethacin, an inhibitor 
of cyclo-oxygenase (15),  led  to  a  64%  decrease  in  prostaglandin  synthesis  with  a 
compensatory increase in the percentage of 20:4 converted to HETEs. Treatment of 
macrophages with the lipoxygenase inhibitor NDGA (16) produced a  79% reduction 
in  HETEs  synthesis  and  a  slight  inhibition  (17%)  of prostaglandin  synthesis.  In 
contrast, ETYA, an acetylenic analog of 20:4 reported to block both cyclo-oxygenase 540  MACROPHAGE  ARACHIDONIC  ACID  METABOLISM 
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FIO.  3.  HPLC chromatograms of prostaglandins. Separations were carried out on ultrasphere C 18 
columns eluted with solvent 3.  (A)  nH-labeled prostaglandin and TXBz standards.  (B)  Resident 
macrophage products. Cuhures were incubated for 20 min in a-MEM containing 0.5 ptCi of [3H]- 
20:4.  Medium  was  extracted  and  subjected  to  HPLC  using solvent  1.  Fractions  4-10  (Fig.  2) 
containing cyclo-oxygenase products were  pooled  and evaporated  to  dryness under a  stream of 
nitrogen. The residue was dissolved in solvent 3 before chromatography in the same solvent, 
TABLE  I 
Effect of Cyclo-oxygenase and Lipoxygenase  Inhibitors  on 20:4 Metabolism 
Addition  Concentration 
Percent of radiolabel in medium 
Prostaglandin  HETEs  20:4 
ILg/mt 
None  --  35.3  44.9  19.8 
Indomethacin  5  12.6  81.6  5.8 
NDGA  0.30  29.4  9.3  61.3 
ETYA  2  16.4  20.1  63.5 
Macrophages  were  isolated  and  incubated  overnight  in  a-MEM  plus  10%  FCS. 
Cultures were washed three times with PD and overlaid with fresh ~t-MEM containing 
the  indicated  concentrations of inhibitors.  After  60  min  incubation  at  37°C  the 
medium was removed, and fresh a-MEM containing inhibitors and 0.5 p,  Ci of [8H]- 
20:4 was added.  After an additional  20  min incubation  at  37°C  the medium was 
removed, and  an  aliquot  counted.  Macrophages were  scraped  into  I  ml of 0.05% 
Triton X-100 and the radiolabel content determined. The medium was extracted for 
20:4  metabolites.  Medium  extracts were  subjected  to  HPLC  on  uhrasphere C-18 
columns eluted sequentially with 80 ml of solvent 1 and 40 ml of solvent 2. Medium 
extracts of duplicate 35-mm cultures were pooled before HPLC. Data are presented 
as the percent of the total ~H recovered in HPLC effluents. The 3H in fractions 3-10 
is listed as prostaglandins, fractions 11-40 as HETEs, and fractions 90-105 as 20:4. Addition  Concentrat ion 
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and lipoxygenase (17), inhibited prostaglandin (54%)  and HETEs  (55%)  production 
to the same extent. 
A  higher percentage of radiolabel in the medium of cultures treated with NDGA 
or ETYA was recovered as unreacted 20:4 than in controls (no drug) or indomethacin- 
treated cultures.  This suggested that  NDGA  and  ETYA  may also inhibit the acyl- 
transferase  which  catalyzes  esterification  of  20:4  into  macrophage  phospholipids. 
However, as shown  in Table II, the percentage of exogenous  20:4  incorporated by 
drug-treated cultures was  greater  (20  :l: 5%)  than  that  of controls.  Uptake of 20:4 
therefore occurred in the presence of drugs. 
20:4 Metabolism  by C. parvum-elicited Macrophages.  Maerophages were elicited by a 
single intraperitoneal injection of C. parvum and harvested after  11-14 d. These cells 
were cultured by the same methods used for resident macrophages. On exposure to 
[3H]20:4  in  serum-free  medium,  C.  parvum-elicited  macrophages  incorporated  over 
twofold (70:1: 3%, mean :t: SD, n =  3) more fatty acid into cell phospholipids than did 
resident cells (34%). In addition, only  17% of the radiolabel remaining in the culture 
medium of elicited cells was recovered as 20:4 oxygenated metabolites. HPLC profiles 
of media extracts from elicited cells were characterized by a  small peak of prostaglan- 
dins, the absence or near absence of HETEs,  and a  predominant  peak of unreacted 
20:4  (Fig. 4). Of the aH recovered in the medium, prostaglandins, HETEs,  and 20:4 
represented  12.5 ±  2.1, 4.1  _+  1.7, and 83.5  ±  0.5%, respectively, of the total (n =  2). 
Separation of the cyclo-oxygenase products formed by C. parvum-elicited cells showed 
(Fig. 5) that the small percentage of 20:4 metabolized via this pathway was recovered 
as 6-ketoPGFl~, TXB2,  PGF2~, and PGE2 in proportions of 1:1.58:3.25:5.45  (n =  3). 
These profiles were strikingly different from those obtained from the cyclo-oxygenase 
products generated by resident maerophages (Fig. 3). 
Relationship  between 20:4 Esterification  and Synthesis of 20:4 Oxygenated Products.  The 
above  experiments  indicated  that  exogenous  20:4  supplied  to  macrophages  main- 
tained in serum-free medium is esterified into cell phospholipid and also converted to 
TABLE II 
Effect of Cyclo-oxygenase and Lipoxygenase Inhibitors on the Uptake of 20:4 
by Macrophages Cultured in Serum-free a-MEM 
Percent 20:4 incorporated by 
macrophages 
10 min  20 min 
#g/ml  % 
None  --  49.7:1:2.2  48.5:1:0.6 
Indomethacin  5  56.9 :t: 3.7  54.1 :t: 0.8 
NDGA  0.30  58.4 3= 1.7  61.2 :t 2.0 
ETYA  2  58.3:1:3.6  59.7 +  1.2 
Macrophages  were isolated  and incubated overnight  in  a-MEM plus  10% 
FCS. Cultures  were washed  three times in PD and overlaid with a-MEM 
containing the indicated concentrations of inhibitors. After 60 min incubation 
at 37°C the medium was removed and the cultures exposed to fresh a-MEM 
containing 0.5 #Ci  [SH]20:4 and  inhibitors.  Medium was  removed  at  the 
indicated times and the macrophages were scraped into  1 ml of 0.05% Triton 
X-100. The radiolabel content of medium and cell suspensions was determined 
in aliquots of each. Data are reported as duplicate determination on triplicate 
cultures (mean + SD) of the total recovered all. 542  MACROPHAGE  ARACHIDONIC  ACID  METABOLISM 
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FIo.  4.  HPLC chromatogram of 20:4  products formed by  C. parvum-elicited macrophages. The 
details of the experimental  protocol  are  the same as  those described under  Fig.  2  for resident 
macrophages. 
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FIG. 5.  HPLC chromatogram of cyclo-oxygenase products formed by (7. parvum-elicited macro- 
phages.  The  experimental  details  are  described  under  Fig.  3.  (A)  nil-labeled  standards;  (B) 
macrophage products. 
cyclo-oxygenase and lipoxygenase products.  We questioned  whether esterification is 
an  initial  step  in  20:4  metabolism  and  this  is  followed  by  de-esterification  and 
conversion  to  a  spectrum  of products.  To  test  this  possibility,  we  carried  out  the 
following experiment. Resident macrophages were labeled in ot-MEM (no serum) for 
80  100  120 SCOTT,  PAWLOWSKI,  ANDREACH,  AND  COHN  543 
20 min with 0.5 #Ci (8.3  nM) of [3H]20:4 and washed with PD. As shown in Fig.  1, 
the remaining cell-associated radiolabel  (35% of the original) represented fatty acid 
incorporated into cell phospholipid. Subsequent exposure of these cultures to a higher 
concentration (10  -'6 M) of unlabeled 20:4 would be expected to promote release of the 
esterified radiolabeled fatty acid in the form of oxygenated metabolites if the above 
construct were true. However, the quantities of tritium recovered in the medium of 
cultures exposed to unlabeled 20:4 were comparable to the low levels obtained from 
controls similarly labeled and incubated in a-MEM  alone (Fig. 6). Other groups of 
cultures  were  labeled  with  [aH]20:4,  washed,  and  again  overlaid with  0.5  #Ci  of 
[aH]20:4. The results indicated that macrophages readily esterified and metabolized 
the additional radiolabeled fatty acid to the same extent seen with the initial exposure. 
In  contrast,  release  of cell  associated  radiolabel  occurred when  labeled  cells  were 
challenged with a maximal dose of 160 #g zymosan. The extent of release (35%) and 
the spectrum of products formed were identical to those reported previously (1)  for 
phagocytizing cultures prelabeled with [aH]20:4 in serum-containing medium. 
We infer the following from these results.  First,  20:4 incorporated into cell phos- 
pholipid from serum-free medium represents a metabolically stable pool of fatty acid 
in resting macrophages. Thus, esterifieation of 20:4 and synthesis of 20:4 oxygenated 
metabolites  appear  to  be  mutually  exclusive reactions.  Second,  we  are  unable  to 
distinguish  in functional terms between the cell phospholipid pools labeled by 20:4 
supplied in serum-free medium and those labeled in the presence of serum. 
Discussion 
It  is  becoming increasingly clear  that  macrophages  are  a  major source of 20:4 
metabolites.  After exposure to  a  particulate or soluble trigger, endogenous 20:4  is 
released from membrane phospholipids and converted to a complex mixture of cyclo- 
oxygenase and  lipoxygenase products  (1-3).  In  this  report, we  show  that  resident 
peritoneal maerophages also metabolize a  large proportion of exogenously supplied 
20:4 in the absence of a discernible trigger. This pathway yields qualitatively similar 
products  to  those  generated  in  response  to  a  phagocytic  stimulus,  but  relative 
proportions  of metabolites  differ  considerably  (Table  III).  It  is  apparent  that  a 
fourfold greater  percentage of exogenously supplied  20:4  is  converted to  HETEs 
together with three- to fivefold decrease in the ratio of PGE2 to prostacyclin (recovered 
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FIG.  6.  Release of all by macrophages prelabeled with [aH]20:4 and exposed to 10  -6 M  unlabeled 
20:4.  Cultures in  35-ram diameter plastic dishes were incubated for 20 rain  at  37°C in a-MEM  a  containing 0.5 #Ci of [ H]20:4. After washing, the cultures were overlaid at time =  0 with ot-MEM 
or a-MEM containing 10  -e M  unlabeled 20:4. Aliquots of medium were removed at the indicated 
times and the radioactivity determined. O, a-MEM plus 10  -~ M  20:4; O, a-MEM alone. 544  MACROPHAGE  ARACHIDONIC ACID METABOLISM 
TABLE  III 
Cyclo-oxygenase and Lipoxygenase Products Formed by Resident Macrophages 
from Exogenous and Endogenous Pathways 
Product 
Proportions of 20:4 metabo|ites* 
Exogenous  Endogenous 
pathway  S  pathway§ 
PGE2  9  40 
6-ketoPGFa.  24  25 
H ETEs  67  15 
Leukotriene C  <3  15-20 
* The  proportions  of metabolites  rather  than  molar quantities  are  given, 
because  the  absolute  amounts  of products  generated  by  the  exogenous 
pathway is variable and dependent  on  the available  arachidonic  acid in 
extracellular fluid. 
:l: Resting  macrophages  in oe-MEM (no serum)  were exposed to 0.5 #Ci  of 
[3H]20:4 for  20  min  at  37°C. The  isolation  and  identification  of 20:4 
oxygenated metabolites is described in Materials and Methods. 
§ Maerophages were labeled overnight  with 0.5 #Ci of [SH]20:4 in oe-MEM 
plus 10% FCS. Cultures were washed and exposed to maximal stimulus of 
160/./.g zymosan for 90 min (1). The isolation and identification of products 
was carried out as described in Materials and Methods. 
as 6-ketoPGFl~).  2 In contrast, macrophages appear unable to utilize fatty acid in the 
medium for leukotriene C  (a slow-reacting substance)  synthesis, although slow-react- 
ing substance represents up  to  15-20%  of the metabolites derived from  endogenous 
20:4 (4, 5). 
Within 5  min, approximately one-third of the exogenously supplied 20:4 is found 
esterified into cell phospholipid and two-thirds is metabolized to oxygenated products 
and  recovered in the extracellular medium.  We questioned whether esterification is 
obligatory for the localization and transfer of 20:4 to the site of metabolite synthesis. 
This  seems  not  to  be  the  case.  Rather,  incorporation  into  cell  phospholipids  and 
synthesis of 20:4 oxygenated products represent distinct metabolic fates of exogenous 
20:4.  This  situation  contrasts  with  our  previous  studies  which  used  macrophages 
exposed to a  particulate, zymosan stimulus  (1). Under these circumstances,  [aH]20:4 
was incubated with cells in the presence of serum for 16 h. Over 70% of the fatty acid 
taken  up  was  incorporated  into  phospholipids.  Subsequent  production  of  cyclo- 
oxygenase and  lipoxygenase products was contingent  on  20:4 release, which ensures 
only upon exposure to soluble stimuli  (3)  or upon  interaction of particulate ligands 
with  specific macrophage  surface  receptors  (18).  The  different  proportions  of 20:4 
oxygenated metabolites produced in the two experimental situations may be explained 
by the existence of separate phospholipid 20:4 and cyclo-oxygenase, and lipoxygenase 
compartments.  In  the  exogenous  pathway,  plasma  membrane-associated  activities 
may  metabolize  fatty  acid  in  the  medium,  whereas  phospholipid  20:4  released  by 
phagocytizing cells may be derived from microsomal and other intracytoplasmic pools 
and metabolized at these sites. Obviously, cell fractionation studies are required and 
should provide insights into these questions. 
Distinct mixtures of products with proinflammatory activities accumulate from the 
"exogenous" and "endogenous" pathways. This together with the modulation evident 
2 Prostacyelin is unstable in aqueous solutions and is recoverd as 6-ketoPGF~.. SCOTT,  PAWLOWSKI, ANDREACH, AND COHN  545 
with elicited macrophages suggests  a  mediator role  of macrophage-derived cyclo- 
oxygenase and lipoxygenase products in the control of inflammation. For example, 
one might expect exogenous metabolites to be formed during an acute inflammatory 
response  when  20:4  is  released  from granulocytes and  other tissue  products.  The 
resident cell cyclo-oxygenase products, PGE2 and prostacyclin, would be expected to 
promote the response. Subsequent macrophage activation leads to down regulation of 
synthetic capacity and  the  production of the  vasoconstrictors,  PGF2~ and  TXB2, 
which may be factors in controlling the exacerbation of both cellular and humoral 
infiltrates. Too  little is  known concerning the physiologic  activities of HETEs  to 
include  them  in  such  a  construct.  One  exception  is  leukotriene  B  (5(S), 12(R)- 
dihydroxy-6,8,10,114- (cis/trans/trans/cis)-eicosatetraenoic  acid),  which  has  been  re- 
ported to be a chemotactic factor for neutrophils with activity comparable to that of 
the  anaphylatoxin C5a  (19, 20). However,  it  remains  to  be  determined whether 
macrophages synthesize leukotriene B. 
In summary, resting macrophages quantitatively metabolize exogenously supplied 
20:4 in concentrations of up to 10  -6 M without loss of cell viability. Other cell types, 
including neutrophils  (8)  and  endothelial cells  (21) are  also  reported  to  convert 
exogenous  20:4 to oxygenated products in the absence of a  stimulus, however the 
quantity of fatty acid metabolized in comparison is small. Thus, macrophages contain 
high levels of cyclo-oxygenase and lipoxygenase activities, a contributing factor in the 
effectiveness of these cells as a source of 20:4 oxygenated metabolites. 
Summary 
Resident mouse peritoneal macrophages rapidly metabolize free arachidonic acid 
(20:4) in the absence of a discernible  trigger.  After a 20-min incubation in serumless 
medium, one-third of the fatty acid was found esterified in cell phospholipid and two- 
thirds was metabolized to oxygenated products which were recovered  in the culture 
medium. 
The 20:4 oxygenated metabolites were identified by reverse-phase high performance 
liquid chromatography as hydroxyeicosatetraenoic acids  (HETEs)  and 6-keto  pros- 
taglandin FI~ (6-ketoPGFl~),  the stable form of prostacyclin, together with prosta- 
glandin E2 (PGE2) in proportions of 67:24:9.  Inhibitor studies using indomethacin, 
nordihydroguaiaretic acid, and 5,8,11,14-eicosatetraenoic  acid confirmed these me- 
tabolites to be lipoxygenase and cyclo-oxygenase products. The proportion of  products 
differs considerably from those generated from phospholipid 20:4 in response  to a 
phagocytic stimulus (HETEs:6-ketoPGFl~:PGE2:leukotriene C, 15:25:40:15-20).  Cor- 
nyebacterium parvum-elicited  macrophages incorporated a  higher percentage (70%) of 
exogenously supplied  20:4  and  converted  <20%  of the  fatty acid  to  oxygenated 
metabolites. Cyclo-oxygenase products (PGE2, PGF2~, TXB2, and 6-ketoPGFl~)  rep- 
resented the major 20:4  metabolites  (74%) synthesized by these  activated macro- 
phages. 
Esterification of 20:4 into cell phospholipids appeared not to be an initial obligatory 
step  for  synthesis  of 20:4  oxygenated products  by  this  route.  To  the  contrary, 
incorporation of 20:4  into cell lipids and metabolism via the cyclo-oxygenase  and 
lipoxygenase pathways represent  distinct  metabolic  fates  of exogenously supplied 
20:4. 
These observations establish that resting macrophages contain high levels of cyclo- 546  MACROPHAGE ARACHIDONIC ACID METABOLISM 
oxygenase and  lipoxygenase  activity  and  suggest  macrophages  can  synthesize  lipid 
mediators of inflammation in the absence of an inflammatory stimulus. 
Received  for publication 20 October 198l. 
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